Scientists map out how childhood brain tumors relapse

Dec 30, 2014

1 min read

Researchers have discovered the unique genetic paths that the childhood brain tumour medulloblastoma follows when the disease comes back, according to research published in Cancer Cell today.

Comments

Unexpected discovery points to a possible route for childhood brain tumor treatments

Turning Pediatric Cancer Discoveries Into Medicines Requires Better Connections

Removing immune 'brake' improves CAR T-cell therapy for pediatric bone cancer

Cardiometabolic Risk in Childhood Cancer Survivors Treated With Anthracyclines

Hodgkin Lymphoma Survivors Face Higher Long-Term Mortality

Emotional health supports physical health in survivors of childhood cancer

Hidden aggressive cells reveal why some lower-risk childhood cancers turn deadly

Personalized T-cell therapy eliminates detectable metastatic kidney tumor in adolescent after multiple relapses

Protective drug dexrazoxane reduces heart damage in pediatric cancer survivors years after treatment ends

MBNL1 was identified as a potential cancer drug target for a type of childhood leukemia

Recent Posts